PU Linmei, ZHANG Hongyan, CHEN Xingqiong, CHEN Shifen, NI Yuanyuan, SONG Xian. Concentration of amphotericin B in blood based on two-dimensional high performance liquid chromatography[J]. Journal of Clinical Medicine in Practice, 2022, 26(16): 117-121. DOI: 10.7619/jcmp.20220148
Citation: PU Linmei, ZHANG Hongyan, CHEN Xingqiong, CHEN Shifen, NI Yuanyuan, SONG Xian. Concentration of amphotericin B in blood based on two-dimensional high performance liquid chromatography[J]. Journal of Clinical Medicine in Practice, 2022, 26(16): 117-121. DOI: 10.7619/jcmp.20220148

Concentration of amphotericin B in blood based on two-dimensional high performance liquid chromatography

More Information
  • Received Date: January 11, 2022
  • Available Online: September 02, 2022
  • Objective 

    To establish a method to determine concentration of amphotericin B in blood based on two-dimensional high performance liquid chromatography method.

    Methods 

    Aston SX1 (3.5 mm×25.0 mm, 5.0 μm) was used as the first-dimensional chromatographic column, mobile phase VmethanolVacetonitrileVwater (25.0 mmoL/L ammonium phosphate salt solution)=1∶3∶3, flow rate was 0.7 mL/min. The second-dimensional column was used Aston SCB (4.6 mm×125.0 mm, 5.0 μm), mobile phase Vwater (25.0 mmol/L ammonium phosphate solution)∶Vwater (1.0 mmol/L diammonium hydrogen phosphate solution)∶VmethanolVAcetonitrile=10∶35∶10∶45, flow rate was 1.0 mL/min. Aston SCB (4.6 mm×10.0 mm, 3.5 μm) was used in the middle column, and the auxiliary mobile phase was pure water. The detection wave length was 380 nm, the column temperature was 40 ℃, and the injection volume was 300 μL.

    Results 

    Amphotericin B had a good linear relationship with peak area in the range of 0.059 to 12.31 μg/mL (r=0.999 9), the lowest limit of quantification was 0.04 μg/mL, the detection limit was 0.01 μg/mL, and the recovery rate was 98.79% to 99.39%. The extraction recovery rate was 98.50% to 99.00%, and relative standard deviation (RSD) of the intra-day and inter-day precision was less than 3.00%.

    Conclusion 

    The plasma concentration of amphotericin B based on two-dimensional high performance liquid chromatography has the characteristics of high sensitivity, good reproducibility, high degree of automation and simple sample processing. It meets the requirements of serum sample detection and can be used for clinical monitoring of amphotericin B plasma concentration.

  • [1]
    SAID R, ARAFAT B, ARAFAT T. High performance liquid chromatography - Mass spectrometric bioanalytical method for the determination of dapoxetine in human plasma: application for bioequivalence study[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2020, 1149: 122154. doi: 10.1016/j.jchromb.2020.122154
    [2]
    中国医药教育协会感染疾病专业委员会. 抗菌药物药代动力学/药效学理论临床应用专家共识[J]. 中华结核和呼吸杂志, 2018, 41(6): 409-446. doi: 10.3760/cma.j.issn.1001-0939.2018.06.004
    [3]
    GROLL A H, RIJNDERS B J A, WALSH T J, et al. Clinical pharmacokinetics, pharmacodynamics, safety and efficacy of liposomal amphotericin B[J]. Clin Infect Dis, 2019, 68(Suppl 4): S260-S274.
    [4]
    LIU Y, HAN F L, LIU Y J, et al. Determination of biogenic amines in wine using modified liquid-liquid extraction with high performance liquid chromatography-fluorescence detector[J]. Food Anal Methods, 2020, 13(4): 911-922. doi: 10.1007/s12161-020-01710-w
    [5]
    ASHBEE H R, BARNES R A, JOHNSON E M, et al. Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology[J]. J Antimicrob Chemother, 2014, 69(5): 1162-1176. doi: 10.1093/jac/dkt508
    [6]
    BARCO S, ZUNINO A, D'AVOLIO A, et al. A rapid and robust UHPLC-DAD method for the quantification of amphotericin B in human plasma[J]. J Pharm Biomed Anal, 2017, 138: 142-145. doi: 10.1016/j.jpba.2017.01.048
    [7]
    LESTNER J M, GROLL A H, ALJAYYOUSSI G, et al. Population pharmacokinetics of liposomal amphotericin B in immunocompromised children[J]. Antimicrob Agents Chemother, 2016, 60(12): 7340-7346. doi: 10.1128/AAC.01427-16
    [8]
    叶珍洁, 胡盈莹. 高效液相色谱法测定人血浆中两性霉素B的浓度[J]. 中国医院用药评价与分析, 2018, 18(9): 1185-1187. https://www.cnki.com.cn/Article/CJFDTOTAL-YYPF201809008.htm
    [9]
    孟现民, 张莉, 刘荣, 等. 高效液相色谱法测定人血浆和脑脊液中的两性霉素B[J]. 中国医院药学杂志, 2009, 29(19): 1617-1619. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYZ200919008.htm
    [10]
    张寒娟, 陈永妍, 王高彪, 等. 新型二维液相色谱快速测定丙戊酸血药浓度的研究[J]. 中国医院药学杂志, 2018, 38(13): 1394-1398. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYZ201813012.htm
    [11]
    BEKERSKY I, FIELDING R M, DRESSLER D E, et al. Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans[J]. Antimicrob Agents Chemother, 2002, 46(3): 828-833. doi: 10.1128/AAC.46.3.828-833.2002
    [12]
    王峰, 朱运贵, 罗雪梅, 等. 新型二维液相色谱测定百草枯尿液浓度的研究[J]. 中国药学杂志, 2017, 52(10): 871-879. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYX201710012.htm
    [13]
    刘朝霞, 周亚楠, 何兰, 等. 二维液相色谱技术在药物分析中的应用[J]. 中国药学杂志, 2019, 54(12): 941-946. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYX201912001.htm
    [14]
    刘宇, 李林, 王锋. 新型二维液相色谱法测定人血浆中阿立哌唑的浓度[J]. 中国药物滥用防治杂志, 2018, 24(3): 150-153. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYLF201803007.htm
    [15]
    CAO L D, ZHANG H, ZHANG H J, et al. Determination of propionylbrassinolide and its impurities by high-performance liquid chromatography with evaporative light scattering detection[J]. Molecules, 2018, 23(3): E531. doi: 10.3390/molecules23030531
    [16]
    王敏, 柳航, 金路, 等. 酶放大免疫分析法与二维高效液相色谱法监测万古霉素血药浓度的比较[J]. 药学与临床研究, 2018, 26(1): 26-29. https://www.cnki.com.cn/Article/CJFDTOTAL-YXLY201801008.htm
    [17]
    WANG X C, MOHAMMAD I S, FAN L F, et al. Delivery strategies of amphotericin B for invasive fungal infections[J]. Acta Pharm Sin B, 2021, 11(8): 2585-2604. doi: 10.1016/j.apsb.2021.04.010
  • Related Articles

    [1]CHEN Yiliang, ZHANG Yinxu, CHE Zhongguang. Effect of intestinal microecological interventionon complications after operation and during chemotherapy in patients with colon cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(20): 73-77. DOI: 10.7619/jcmp.20212087
    [2]LI Lin, QIAO Hua, LIU Ying, CHEN Chen, LI Qin. Effect of continuous nursing based on Wechat platform in patients undergoing colostomy[J]. Journal of Clinical Medicine in Practice, 2019, 23(21): 118-121. DOI: 10.7619/jcmp.201921034
    [3]QIAN Lei, JI Xiaojing, DAI Huanhuan, YANG Qun, XUE Jiajia, XU Jun, YU Xintao. Effect of PDCA circulation management on complicationsand self-care ability of hemodialysis patients with arteriovenous internal fistula[J]. Journal of Clinical Medicine in Practice, 2019, 23(13): 112-115. DOI: 10.7619/jcmp.201913032
    [4]CHENG Xiaoqin, LI Junfang. Effect of extended care on the complications and quality of life in patients with permanent enterostoma[J]. Journal of Clinical Medicine in Practice, 2018, (8): 60-62. DOI: 10.7619/jcmp.201808018
    [5]FANG Qiong, ZHANG Wei, ZHU Ying. Effect of comprehensive nursing on reducing postoperative complications of neonatal enterostomy[J]. Journal of Clinical Medicine in Practice, 2018, (6): 107-110. DOI: 10.7619/jcmp.201806031
    [6]LI Jie, ZHANG Zifeng. Application of evidence-based nursing in prevention of complications in young and middle-aged patients with paraplegia[J]. Journal of Clinical Medicine in Practice, 2014, (4): 42-45. DOI: 10.7619/jcmp.201404014
    [7]WU Xiaoli, WANG Fang, JI Jianhong. Influence of gastric lavage monitoring system for detecting liquid input-output balance on complications of gastric lavage[J]. Journal of Clinical Medicine in Practice, 2013, (20): 85-87. DOI: 10.7619/jcmp.201320029
    [8]DONG Shuling, DONG Lingzhi, REN Zhiyan. Influence of nursing intervention on reduction of incidence rate of complications in hypertension patients[J]. Journal of Clinical Medicine in Practice, 2013, (20): 18-20. DOI: 10.7619/jcmp.201320006
    [9]ZHUANG Zhaorong, YIN Daju. Nursing for gastric cancer patients with early postoperative complications[J]. Journal of Clinical Medicine in Practice, 2013, (12): 14-16,19. DOI: 10.7619/jcmp.201312006
    [10]CHEN Yunlan, QIU Meiling. Nursing for postoperative complications in patients with hysterectomy[J]. Journal of Clinical Medicine in Practice, 2013, (10): 95-97. DOI: 10.7619/jcmp.201310035
  • Cited by

    Periodical cited type(7)

    1. 刘娟,王凤兰. 川崎病患儿冠状动脉病变的影响因素分析及预测模型构建. 国际医药卫生导报. 2025(01): 60-65 .
    2. 刘威,张兰. 婴儿川崎病冠状动脉病变的临床特点及危险因素分析. 分子诊断与治疗杂志. 2025(01): 38-40+45 .
    3. 徐树红,姜军. 川崎病患儿冠脉病变发生的危险因素模型构建及分析. 医学理论与实践. 2024(13): 2290-2292 .
    4. 张春燕. 白细胞介素-6/白蛋白比值与川崎病患儿冠状动脉损害的相关性研究. 中国实用医刊. 2023(11): 16-20 .
    5. 高健,陈雨青. 川崎病患儿发生血管损伤的影响因素. 血管与腔内血管外科杂志. 2023(07): 846-849+863 .
    6. 田慧,郝晓燕,祁洁,李莉,郭瑞霞,尉志红. 儿童川崎病的危险因素分析及列线图模型构建. 中西医结合心脑血管病杂志. 2023(17): 3278-3280 .
    7. 张惠,张晓斌,陈俊义. 川崎病患儿急性期血脂水平与冠脉病变关系的研究. 中国卫生标准管理. 2023(24): 23-27 .

    Other cited types(2)

Catalog

    Article views PDF downloads Cited by(9)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return